Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
Northern California Comprehensive Thalassemia Center
Search form
Search...
Facebook
Twitter
About Us
Our Team
Contact Us
About Thalassemia
Demographics
Diet Guidelines for Thalassemia Patients
Exercise
Healthy Diet
Symptoms & Diagnosis
Types of Thalassemia
Treatment
Bone Marrow Transplant & Gene Therapy
Cardiac Complications
Chelation Therapy
Endocrine Complications
Fertility & Reproductive Health
Intra-uterine Therapy Research
Standards of Care
Transfusions
Research & Clinical Trials
Clinical Trials
Stem Cell Therapy
Resources
Brochures & Newsletters
Health Resources
Publications
News
You are here
Home
>
Safety of deferasirox in sickle cell disease patients with co-existing liver impairment – response to Sinakos et al
Safety of deferasirox in sickle cell disease patients with co-existing liver impairment – response to Sinakos et al
British Journal of Haematology
Safety of deferasirox in sickle cell disease patients with co-existing liver impairment – response to Sinakos et al
Vichinsky E.